Inflammopharmacology

ISSN: 0925-4692• JCR: INFLAMMOPHARMACOLOGYSpringer NatureSwitzerland
Visit Journal Homepage
5.3
2025 Impact Factor
5.2
5-Year Impact Factor
Q1
JCR Quartile
B2
CAS Block

Inflammopharmacology impact factor and JCR quartile

The 2025 impact factor for Inflammopharmacology is 5.3. The 5-year impact factor is 5.2. The journal is listed as JCR Q1 in the current Journal Metrics dataset.

Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.

If you searched for Inflammopharmacology impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.

2025 impact factor and source check

This page is designed for exact-title searches such as Inflammopharmacology impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.

For high-stakes submission decisions, verify the title against the publisher record at the journal homepage, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.

Journal Details

Total Articles
2,863
H-Index
90
Open Access
Hybrid
APC
$4,390 USD
Subject Areas
PharmacologyPharmacologyRheumatologyMolecular BiologySurgery

Article Volume

2021
114
2022
221
2023
273
2024
220
2025
458
2026
109
Back to Search